Swedish Orphan Biovitrum AB (publ)

DB:B6E Stock Report

Market Cap: €9.3b

Swedish Orphan Biovitrum Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:B6E Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Aug 24Buy€901,269Guido OelkersIndividual70,000€12.88
30 Aug 24Buy€1,088,295Torbjörn HallbergIndividual84,526€12.88
30 Aug 24Sell€7,578Katy MazibukoIndividual269€28.17
30 Aug 24Sell€42,292Katy MazibukoIndividual1,500€28.19
28 Aug 24Sell€1,935,305Guido OelkersIndividual70,000€27.65
28 Aug 24Sell€2,377,816Torbjörn HallbergIndividual84,526€28.13
27 Aug 24Sell€2,611,434Henrik StenqvistIndividual96,111€27.17
27 Aug 24Sell€2,743,950Guido OelkersIndividual100,000€27.44
27 Aug 24Sell€566,289Armin ReiningerIndividual20,452€27.69
27 Aug 24Sell€1,887,254Daniel RankinIndividual68,535€27.61
12 Aug 24Buy€2,034Katy MazibukoIndividual86€23.65
26 Jul 24Buy€1,244,534Guido OelkersIndividual100,000€12.45
25 Jul 24Sell€4,991,787Guido OelkersIndividual200,000€24.99
25 Jul 24Sell€1,378,406Christine WesstromIndividual55,250€24.95
23 Jun 24Sell€2,185,636Mahmood LadhaIndividual84,585€25.84
04 Jun 24Sell€3,292,596Duane BarnesIndividual132,401€24.87
04 Jun 24Sell€2,062,495Armin ReiningerIndividual83,219€24.78
29 May 24Sell€2,627,099Guido OelkersIndividual110,000€23.88
28 May 24Sell€2,644,372Guido OelkersIndividual110,000€24.04
08 May 24Buy€860,104Daniel RankinIndividual49,344€17.43
08 May 24Sell€1,401,533Daniel RankinIndividual58,480€24.16

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of B6E?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders743,1640.216%
General Public33,263,5479.69%
VC/PE Firms122,964,76035.8%
Institutions186,464,36554.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 86.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
35.8%
Investor AB (publ)
122,964,760€3.3b0%5.64%
10.2%
Morgan Stanley, Investment Banking and Brokerage Investments
35,043,624€947.4m0%0.11%
6.12%
Fourth Swedish National Pension Fund (AP4)
21,010,927€568.1m0%2.47%
4.64%
State Street Global Advisors, Inc.
15,937,784€430.9m0%0.02%
3.69%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
12,656,839€342.2m0%0.09%
3.01%
Swedbank Robur Fonder AB
10,332,683€279.4m0%0.19%
2.59%
BNY Asset Management
8,889,547€240.3m0%0.05%
2.54%
Polar Capital Holdings Plc
8,727,139€235.9m0%0.87%
2.46%
AMF Fonder AB
8,431,488€228.0m0%0.68%
2.25%
Handelsbanken Asset Management
7,717,648€208.7m0%0.32%
2.1%
The Vanguard Group, Inc.
7,221,036€195.2m0.15%no data
1.67%
BlackRock, Inc.
5,733,514€155.0m-5.02%no data
1.38%
Norges Bank Investment Management
4,725,721€127.8m0%0.01%
1.02%
Carnegie Fonder AB
3,496,030€94.5m37.5%0.98%
0.96%
Artisan Partners Limited Partnership
3,296,034€89.1m0%0.07%
0.77%
Nordea Investment Management, AB
2,653,574€71.7m0%0.05%
0.77%
Cliens Kapitalförvaltning AB
2,636,857€71.3m0%2.17%
0.75%
SEB Investment Management AB
2,585,402€69.9m0%0.14%
0.73%
Lansforsakringar Fondforvaltning AB
2,515,360€68.0m0%0.26%
0.67%
E. Öhman J:or Wealth Management
2,306,031€62.3m0%0.43%
0.63%
Forsta AP-fonden
2,156,703€58.3m0%0.23%
0.39%
Geode Capital Management, LLC
1,325,948€35.8m0.08%no data
0.37%
Storebrand Fonder AB,
1,270,236€34.3m0%0.12%
0.34%
Tredje AP-fonden
1,158,786€31.3m0%0.14%
0.32%
Skandia Fonder AB
1,097,716€29.7m0%0.26%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 17:41
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Swedish Orphan Biovitrum AB (publ) is covered by 29 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexander LindströmABG Sundal Collier
Rosie TurnerBarclays
Brian BalchinBarclays